» Articles » PMID: 24834268

Geographic Trends and Risk of Gastrointestinal Cancer Among Patients with Celiac Disease in Europe and Asian-Pacific Region

Overview
Specialty Gastroenterology
Date 2014 May 17
PMID 24834268
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Celiac disease is an autoimmune disorder that affects genetically predisposed individuals upon the ingestion of gluten. It is now considered one of the most common genetic disorders in Europe and Asian Pacific region with a prevalence of up to 2.67% of the population. The true prevalence of celiac disease may still be underestimated. Studies remain limited by sample size and selection bias. Celiac disease predisposes to the development of gastrointestinal malignancies, especially lymphomas and small bowel adenocarcinoma. The risk of developing a celiac disease associated malignancies remains uncertain, despite numerous studies. In Middle Eastern countries, the literature regarding celiac disease has expanded significantly in recent years. These studies reported have largely concentrated on the epidemiology of Celiac disease and there is an absolute and relative paucity of published research regarding celiac disease associated malignancy. The aim of this article is to review the current literature and evaluate the risk of gastrointestinal malignancies among patients with celiac disease and then review studies from the Asian Pacific region of the world.

Citing Articles

Inflammation-Associated Stem Cells in Gastrointestinal Cancers: Their Utility as Prognostic Biomarkers and Therapeutic Targets.

Kumari B, Tiwari A, Meena S, Ahirwar D Cancers (Basel). 2024; 16(18).

PMID: 39335106 PMC: 11429849. DOI: 10.3390/cancers16183134.


Prevalence of malignant neoplasms in celiac disease patients - a nationwide United States population-based study.

Haider M, Al Sbihi A, Reddy S, Green P World J Clin Oncol. 2024; 15(8):1048-1060.

PMID: 39193153 PMC: 11346075. DOI: 10.5306/wjco.v15.i8.1048.


Gastric perforation secondary to T-cell lymphoma.

Fernandez-Alberti J, Irribarra M, Rancati A, Panzardi N, Cora M, Speisky D Ecancermedicalscience. 2023; 17:1498.

PMID: 36816790 PMC: 9937071. DOI: 10.3332/ecancer.2023.1498.


Alpha-enolase involvement in intestinal and extraintestinal manifestations of celiac disease.

Lerner A, Sobolevskaia P, Churilov L, Shoenfeld Y J Transl Autoimmun. 2021; 4:100109.

PMID: 34189450 PMC: 8219987. DOI: 10.1016/j.jtauto.2021.100109.


The effect of education on the knowledge of patients with celiac disease.

Barzegar F, Rostami-Nejad M, Mohaghegh Shalmani H, Sadeghi A, Allahverdi Khani M, Aldulaimi D Gastroenterol Hepatol Bed Bench. 2018; 10(Suppl1):S15-S19.

PMID: 29511466 PMC: 5838175.


References
1.
Selby W, GALLAGHER N . Malignancy in a 19-year experience of adult celiac disease. Dig Dis Sci. 1979; 24(9):684-8. DOI: 10.1007/BF01314465. View

2.
Howdle P, Jalal P, Holmes G, Houlston R . Primary small-bowel malignancy in the UK and its association with coeliac disease. QJM. 2003; 96(5):345-53. DOI: 10.1093/qjmed/hcg058. View

3.
Card T, West J, Holmes G . Risk of malignancy in diagnosed coeliac disease: a 24-year prospective, population-based, cohort study. Aliment Pharmacol Ther. 2004; 20(7):769-75. DOI: 10.1111/j.1365-2036.2004.02177.x. View

4.
Swinson C, Slavin G, Coles E, Booth C . Coeliac disease and malignancy. Lancet. 1983; 1(8316):111-5. DOI: 10.1016/s0140-6736(83)91754-3. View

5.
Schweizer J, Oren A, Mearin M . Cancer in children with celiac disease: a survey of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2001; 33(1):97-100. DOI: 10.1097/00005176-200107000-00020. View